| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Lee Kenneth B Jr is a Director at BCRX, with reported holdings spanning 2 companies. Recent filings cover 5 purchases and 1 sale.
Our model assigns Lee Kenneth B Jr a below-average insider score of 42/100, based on 5 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -24.3%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 | HYPD Hyperion Defi, Inc. | Director | Buy | 10,000 | $2.20 | $22,000.00 | +30.9% | -16.3% | +58.4% | |
| Sep 13, 2021 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 6,000 | $15.35 | $92,100.00 | -19.8% | -25.2% | -15.0% | |
| Jun 15, 2021 | HYPD Hyperion Defi, Inc. | Director | Buy | 6,000 | $5.42 | $32,512.00 | +31.0% | -17.6% | -65.3% | |
| Nov 18, 2019 | BCRX Biocryst Pharmaceuticals Inc | Director | Buy | 5,000 | $1.45 | $7,250.00 | +48.8% | - | - |